These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 36674535)

  • 1. The Role of Inflammation and Therapeutic Concepts in Diabetic Retinopathy-A Short Review.
    Gomułka K; Ruta M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Inflammation in Diabetic Retinopathy.
    Rübsam A; Parikh S; Fort PE
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia and oxidative stress in the causation of diabetic retinopathy.
    Arden GB; Sivaprasad S
    Curr Diabetes Rev; 2011 Sep; 7(5):291-304. PubMed ID: 21916837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic retinopathy.
    Wong TY; Cheung CM; Larsen M; Sharma S; Simó R
    Nat Rev Dis Primers; 2016 Mar; 2():16012. PubMed ID: 27159554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of vascular endothelial growth factor-A
    Morawietz H; Frenzel A; Mieting A; Goettsch W; Valtink M; Roehlecke C; Jászai J; Funk RHW; Becker KA; Engelmann K
    Ther Apher Dial; 2022 Dec; 26 Suppl 1():29-34. PubMed ID: 36468302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diabetic retinopathy: pathogenesis and therapeutic implications].
    Pelikánová T
    Vnitr Lek; 2016; 62(7-8):620-8. PubMed ID: 27627088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cell biology of intraocular vascular diseases].
    Ishibashi T
    Nippon Ganka Gakkai Zasshi; 1999 Dec; 103(12):923-47. PubMed ID: 10643294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Pathogenesis of Endothelial Dysfunction in Diabetic Nephropathy and Retinopathy.
    Yang J; Liu Z
    Front Endocrinol (Lausanne); 2022; 13():816400. PubMed ID: 35692405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose transport, transporters and metabolism in diabetic retinopathy.
    Zhang C; Gu L; Xie H; Liu Y; Huang P; Zhang J; Luo D; Zhang J
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):166995. PubMed ID: 38142757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical scenario behind initiation of diabetic retinopathy in type 2 diabetes mellitus.
    Mondal LK; Bhaduri G; Bhattacharya B
    Indian J Ophthalmol; 2018 Apr; 66(4):535-540. PubMed ID: 29582815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
    Romero-Aroca P; Baget-Bernaldiz M; Pareja-Rios A; Lopez-Galvez M; Navarro-Gil R; Verges R
    J Diabetes Res; 2016; 2016():2156273. PubMed ID: 27761468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
    Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
    Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy.
    Behl T; Kotwani A
    Pharmacol Res; 2015 Sep; 99():137-48. PubMed ID: 26054568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic Retinopathy: Pathophysiology and Treatments.
    Wang W; Lo ACY
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29925789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy.
    Segawa Y; Shirao Y; Yamagishi S; Higashide T; Kobayashi M; Katsuno K; Iyobe A; Harada H; Sato F; Miyata H; Asai H; Nishimura A; Takahira M; Souno T; Segawa Y; Maeda K; Shima K; Mizuno A; Yamamoto H; Kawasaki K
    Ophthalmic Res; 1998; 30(6):333-9. PubMed ID: 9731114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinal Cell Damage in Diabetic Retinopathy.
    Zhou J; Chen B
    Cells; 2023 May; 12(9):. PubMed ID: 37174742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic C-peptide supplementation ameliorates retinal neurodegeneration by inhibiting VEGF-induced pathological events in diabetes.
    Lee AJ; Moon CH; Lee YJ; Jeon HY; Park WS; Ha KS
    FASEB J; 2023 Feb; 37(2):e22763. PubMed ID: 36625326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis.
    Mudaliar S; Hupfeld C; Chao DL
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1235-1244. PubMed ID: 33512450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of extracellular vesicles in diabetic retinopathy.
    Zhu J; Huang J; Sun Y; Xu W; Qian H
    Theranostics; 2024; 14(4):1631-1646. PubMed ID: 38389842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.